Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the HIV Drugs Market Grown from 2024 to 2025?#_x000D_

In the past few years, the HIV drugs market has witnessed consistent growth. The industry is predicted to rise from $34.91 billion in 2024 to $36.41 billion in 2025, with a compound annual growth rate (CAGR) of 4.3%. Various factors have contributed to this growth during the historic period, including heightened government assistance and initiatives, a surge in healthcare spending, a boost in research and development expenditure related to HIV, an increase in HIV infection cases, and growth in awareness coupled with economic development in burgeoning markets._x000D_

_x000D_

#What Growth Rate Is Anticipated for the HIV Drugs Market in the Coming Years?#_x000D_

The HIV pharmaceutical market is anticipated to undergo stable expansion in the forthcoming years. The market is forecasted to reach $42.34 billion by 2029 with a compound annual growth rate (CAGR) of 3.8%. This predicted growth is attributed to several factors such as enhanced government backing and initiatives, escalated healthcare spending, advancements in HIV research and development, an upsurge in HIV infections, boosted awareness, and economic development in emerging markets. Key trends expected during this forecast period comprise of investment in 3D bioprinting technology, novel product innovation, the advent of multi-class combination products for HIV therapy, and investment in strategic partnerships and agreements._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=2834&type=smp_x000D_

_x000D_

#Who Are the Leading Companies in the HIV Drugs Market?#_x000D_

Major companies operating in the HIV drugs market include Gilead Sciences Inc., Johnson & Johnson, Merck & Co. Inc., Boehringer Ingelheim International GmbH, Cipla, Aurobindo Pharma, AbbVie, Emcure Pharmaceuticals, Micro Labs Limited, Northeast Pharmaceutical Group Co. Ltd, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd, Strides Arcolab Limited, Hetero Labs Limited, Shanghai Desano Bio-pharmaceutical Co., Anhui Biochem Biopharmaceutical Co. Ltd., China’s National Health Commission (NHC), Shanghai Xinxing Medicine Co. Ltd., China Meheco Xinxing Pharma Co. Ltd., CytoDyn Inc., Janssen Pharmaceutical, Bavarian Nordic, Roche Laboratories, Pharmstandard, Pharmasyntez, R-Pharm, Alium, ChemRar Group, Gritstone Oncology, Enzolytics Inc., BioClonetics Immunotherapeutics Inc., Dewpoint Therapeutics, Lyndra Therapeutics, Mylan N.V., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Teva Canada, ViiV Healthcare Canada, GSK, Abbott Laboratories, Aspen Pharmacare Limited, Pharmacare Ltd._x000D_

_x000D_

#What Are the Key Drivers of the HIV Drugs Market?#_x000D_

The growth of the HIV drug market is significantly driven by the rising consciousness among individuals about the detection and treatment of HIV. HIV/AIDS, being one of the most persistent illnesses, has heightened awareness due to its widespread prevalence worldwide. This awareness has been evident, for example, when in July 2024, the United States-based Humanitarian aid organization, the United Nations International Children’s Emergency Fund (UNICEF), reported that there were an estimated 40.0 million people living globally with HIV in 2023, including 2.38 million children aged between 0-19. It was further highlighted that in 2023, roughly 685 children were infected with HIV each day, and about 250 children succumbed to AIDS. As such, this rising awareness about HIV’s detection and treatment plays a vital role in propelling the HIV drug market’s growth._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=2834&type=smp_x000D_

_x000D_

#What Are the Key Market Segments in the HIV Drugs Industry?#_x000D_

The HIV drugs market covered in this report is segmented –_x000D_

_x000D_

1) By Type: Nucleoside Reverse Transcriptase Inhibitors (NRT’s), Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s), Protease Inhibitors, Integrase strand transfer inhibitors (INSTIs), Other Types_x000D_

2) By Administration: Oral, Parenteral_x000D_

3) By Application: Hospital Pharmacies, Retail Pharmacies, Other Applications_x000D_

_x000D_

Subsegments:_x000D_

1) By Nucleoside Reverse Transcriptase Inhibitors (NRTIs): Zidovudine (AZT), Lamivudine (3TC), Abacavir (ABC), Tenofovir disoproxil fumarate (TDF), Other NRTIs_x000D_

2) By Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs): Efavirenz (EFV), Nevirapine (NVP), Etravirine (ETR), Rilpivirine (RPV), Other NNRTIs_x000D_

3) By Protease Inhibitors (PIs): Ritonavir (RTV), Lopinavir (LPV), Darunavir (DRV), Atazanavir (ATV), Other PIs_x000D_

4) By Integrase Strand Transfer Inhibitors (INSTIs): Raltegravir (RAL), Dolutegravir (DTG), Bictegravir (BIC), Other INSTIs_x000D_

5) By Other Types: Entry Inhibitors, Fusion Inhibitors, Combination Therapies_x000D_

_x000D_

#What Are the Latest Trends in the HIV Drugs Market?#_x000D_

The key players in the HIV drugs industry are engineering strategic alliances, with a focus on producing Lenacapavir, in an effort to speed up drug development, extend treatment availability, and boost their global market stance. Renowned as a first-of-its-kind HIV-1 capsid inhibitor, Lenacapavir, when used together with other antiretrovirals, targets various phases of the HIV lifecycle, thus becoming a potential treatment option for patients with limited alternatives. For example, in August 2023, a collaboration was struck between Dr. Reddy’s Laboratories, a pharmaceutical company based in India, and Hetero, another India-based pharmaceutical firm, with Gilead Sciences Inc., a biopharmaceutical company based in the US. This alliance with Gilead Sciences allows Dr. Reddy’s Laboratories and Hetero to produce and distribute the HIV drug lenacapavir in around 120 primarily low- and lower-middle-income nations (LMICs). The goal of this effort is to widen the reach of this novel treatment, especially for patients with multi-drug-resistant HIV who have been on extensive treatment plans._x000D_

_x000D_

#Access The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/hiv-drug-global-market-report_x000D_

_x000D_

#What Are the Key Regional Markets in the HIV Drugs Industry?#_x000D_

North America was the largest region in the HIV drugs market share in 2024. Middle East is expected to be the largest growing region in the global HIV drug market during the forecast period. The regions covered in the HIV drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Purchase The Full Report Today:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2834_x000D_

_x000D_

#This Report Delivers Insight On: #_x000D_

1. How big is the hiv drugs market, and how is it changing globally?_x000D_

2. Who are the major companies in the hiv drugs market, and how are they performing?_x000D_

3. What are the key opportunities and risks in the hiv drugs market right now?_x000D_

4. Which products or customer segments are growing the most in the hiv drugs market?_x000D_

5. What factors are helping or slowing down the growth of the hiv drugs market?_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 2071930708_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model